Results from 2 years of follow-up demonstrate the efficacy of a bifocal corneal inlay for correcting presbyopia in emmetropic patients.
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.